Raymond James & Associates Axonics, Inc. Transaction History

Raymond James & Associates

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$47.99 - $60.21 $133,796 - $167,865	-2,788 Reduced 24.61%	8,540 $431,000
Q1 2023 Apr 14, 2023	SELL	$52.6 - $67.34 $392,290 - $502,221	-7,458 Reduced 39.7%	11,328 $618,000
Q4 2022 Feb 08, 2023	BUY	$59.56 - $76.6 $492,799 - $633,788	8,274 Added 78.71%	18,786 $1.17 Million
Q3 2022 Oct 25, 2022	BUY	$57.96 - $78.12 $396,620 - $534,575	6,843 Added 186.51%	10,512 $740,000
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $144,925 - $236,356	3,669 New	3,669 $208,000
Q1 2022 May 11, 2022	SELL	$43.74 - $62.76 $251,811 - $361,309	-5,757 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$50.01 - $73.35 $46,359 - $67,995	927 Added 19.19%	5,757 $322,000
Q3 2021 Nov 02, 2021	SELL	$59.21 - $78.66 $163,656 - $217,416	-2,764 Reduced 36.4%	4,830 $314,000
Q2 2021 Aug 11, 2021	BUY	$51.39 - $66.9 $390,255 - $508,038	7,594 New	7,594 $482,000
Q1 2020 Apr 21, 2020	SELL	$16.44 - $37.73 $144,310 - $331,193	-8,778 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$19.57 - $28.96 $171,785 - $254,210	8,778 New	8,778 $243,000

235

42.8M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.45B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.